GB1513166A - Method of making granules - Google Patents
Method of making granulesInfo
- Publication number
- GB1513166A GB1513166A GB2419175A GB2419175A GB1513166A GB 1513166 A GB1513166 A GB 1513166A GB 2419175 A GB2419175 A GB 2419175A GB 2419175 A GB2419175 A GB 2419175A GB 1513166 A GB1513166 A GB 1513166A
- Authority
- GB
- United Kingdom
- Prior art keywords
- granules
- june
- binder
- heat
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/16—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by suspending the powder material in a gas, e.g. in fluidised beds or as a falling curtain
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19742426812 DE2426812A1 (de) | 1974-06-04 | 1974-06-04 | Verfahren zur herstellung von granulaten |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1513166A true GB1513166A (en) | 1978-06-07 |
Family
ID=5917213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2419175A Expired GB1513166A (en) | 1974-06-04 | 1975-06-04 | Method of making granules |
Country Status (8)
Country | Link |
---|---|
JP (1) | JPS516869A (de) |
AT (1) | AT343083B (de) |
BE (1) | BE829449A (de) |
DE (1) | DE2426812A1 (de) |
FR (1) | FR2273584A1 (de) |
GB (1) | GB1513166A (de) |
LU (1) | LU72652A1 (de) |
NL (1) | NL7506615A (de) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5443846A (en) * | 1990-04-28 | 1995-08-22 | Takeda Chemical Industries, Ltd. | Granulated preparations and method of producing the same |
GB2287880A (en) * | 1994-03-14 | 1995-10-04 | Euro Celtique Sa | Production of sustained release compositions |
US5591452A (en) * | 1993-05-10 | 1997-01-07 | Euro-Celtique, S.A. | Controlled release formulation |
US5700410A (en) * | 1992-10-16 | 1997-12-23 | Nippon Shinyaku Co., Ltd. | Method of manufacturing wax matrices |
US5843480A (en) | 1994-03-14 | 1998-12-01 | Euro-Celtique, S.A. | Controlled release diamorphine formulation |
US5849240A (en) | 1993-11-23 | 1998-12-15 | Euro-Celtique, S.A. | Method of preparing sustained release pharmaceutical compositions |
US5891471A (en) | 1993-11-23 | 1999-04-06 | Euro-Celtique, S.A. | Pharmaceutical multiparticulates |
US5958452A (en) | 1994-11-04 | 1999-09-28 | Euro-Celtique, S.A. | Extruded orally administrable opioid formulations |
US6068855A (en) | 1994-11-03 | 2000-05-30 | Euro-Celtique S. A. | Pharmaceutical composition containing a fusible carrier and method for producing the same |
WO2005123039A1 (en) * | 2004-06-12 | 2005-12-29 | Collegium Pharmaceutical, Inc. | Abuse-deterrent drug formulations |
US8557291B2 (en) | 2002-07-05 | 2013-10-15 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
US8557286B1 (en) | 1999-04-22 | 2013-10-15 | Euroceltique, S.A. | Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix |
US8840928B2 (en) | 2002-07-05 | 2014-09-23 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
US9044398B2 (en) | 2002-07-05 | 2015-06-02 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
US10004729B2 (en) | 2002-07-05 | 2018-06-26 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
CN110507658A (zh) * | 2019-09-18 | 2019-11-29 | 国药集团致君(深圳)制药有限公司 | 头孢呋辛酯药物组合物及其制备方法 |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5429825A (en) * | 1992-06-26 | 1995-07-04 | Mcneil-Ppc, Inc. | Rotomelt granulation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4856577A (de) * | 1971-11-22 | 1973-08-08 |
-
1974
- 1974-06-04 DE DE19742426812 patent/DE2426812A1/de not_active Withdrawn
-
1975
- 1975-05-23 BE BE156677A patent/BE829449A/xx unknown
- 1975-05-27 FR FR7516480A patent/FR2273584A1/fr not_active Withdrawn
- 1975-05-30 AT AT415075A patent/AT343083B/de active
- 1975-06-03 JP JP6697975A patent/JPS516869A/ja active Pending
- 1975-06-04 LU LU72652A patent/LU72652A1/xx unknown
- 1975-06-04 NL NL7506615A patent/NL7506615A/xx not_active Application Discontinuation
- 1975-06-04 GB GB2419175A patent/GB1513166A/en not_active Expired
Cited By (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5443846A (en) * | 1990-04-28 | 1995-08-22 | Takeda Chemical Industries, Ltd. | Granulated preparations and method of producing the same |
US5700410A (en) * | 1992-10-16 | 1997-12-23 | Nippon Shinyaku Co., Ltd. | Method of manufacturing wax matrices |
US6254887B1 (en) | 1993-05-10 | 2001-07-03 | Euro-Celtique S.A. | Controlled release tramadol |
US5591452A (en) * | 1993-05-10 | 1997-01-07 | Euro-Celtique, S.A. | Controlled release formulation |
US6326027B1 (en) | 1993-05-10 | 2001-12-04 | Euro-Celtique S.A. | Controlled release formulation |
US5891471A (en) | 1993-11-23 | 1999-04-06 | Euro-Celtique, S.A. | Pharmaceutical multiparticulates |
US5849240A (en) | 1993-11-23 | 1998-12-15 | Euro-Celtique, S.A. | Method of preparing sustained release pharmaceutical compositions |
US5965163A (en) | 1993-11-23 | 1999-10-12 | Euro-Celtique, S.A. | Substained release compositions and a method of preparing pharmaceutical compositions |
US6162467A (en) | 1993-11-23 | 2000-12-19 | Euro-Celtique, S.A. | Sustained release compositions and a method of preparing pharmaceutical compositions |
GB2287880A (en) * | 1994-03-14 | 1995-10-04 | Euro Celtique Sa | Production of sustained release compositions |
US5843480A (en) | 1994-03-14 | 1998-12-01 | Euro-Celtique, S.A. | Controlled release diamorphine formulation |
US6068855A (en) | 1994-11-03 | 2000-05-30 | Euro-Celtique S. A. | Pharmaceutical composition containing a fusible carrier and method for producing the same |
US6706281B2 (en) | 1994-11-04 | 2004-03-16 | Euro-Celtique, S.A. | Melt-extrusion multiparticulates |
US5958452A (en) | 1994-11-04 | 1999-09-28 | Euro-Celtique, S.A. | Extruded orally administrable opioid formulations |
US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
US6335033B2 (en) | 1994-11-04 | 2002-01-01 | Euro-Celtique, S.A. | Melt-extrusion multiparticulates |
US6261599B1 (en) | 1994-11-04 | 2001-07-17 | Euro-Celtique, S.A. | Melt-extruded orally administrable opioid formulations |
US6743442B2 (en) | 1994-11-04 | 2004-06-01 | Euro-Celtique, S.A. | Melt-extruded orally administrable opioid formulations |
US8557286B1 (en) | 1999-04-22 | 2013-10-15 | Euroceltique, S.A. | Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix |
US9592200B2 (en) | 2002-07-05 | 2017-03-14 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
US10004729B2 (en) | 2002-07-05 | 2018-06-26 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
US8557291B2 (en) | 2002-07-05 | 2013-10-15 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
US10525053B2 (en) | 2002-07-05 | 2020-01-07 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
US9682075B2 (en) | 2002-07-05 | 2017-06-20 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
US8840928B2 (en) | 2002-07-05 | 2014-09-23 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
US9044398B2 (en) | 2002-07-05 | 2015-06-02 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
US9248195B2 (en) | 2002-07-05 | 2016-02-02 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
US8449909B2 (en) | 2004-06-12 | 2013-05-28 | Collegium Pharmaceutical, Inc. | Abuse-deterrent drug formulations |
US8758813B2 (en) | 2004-06-12 | 2014-06-24 | Collegium Pharmaceutical, Inc. | Abuse-deterrent drug formulations |
US9763883B2 (en) | 2004-06-12 | 2017-09-19 | Collegium Pharmaceutical, Inc. | Abuse-deterrent drug formulations |
EP3326617A1 (de) * | 2004-06-12 | 2018-05-30 | Collegium Pharmaceutical, Inc. | Missbrauchsverhindernde arzneimittelformulierungen |
US7771707B2 (en) | 2004-06-12 | 2010-08-10 | Collegium Pharmaceutical, Inc. | Abuse-deterrent drug formulations |
WO2005123039A1 (en) * | 2004-06-12 | 2005-12-29 | Collegium Pharmaceutical, Inc. | Abuse-deterrent drug formulations |
US10525052B2 (en) | 2004-06-12 | 2020-01-07 | Collegium Pharmaceutical, Inc. | Abuse-deterrent drug formulations |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
US9968598B2 (en) | 2016-06-23 | 2018-05-15 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
US10188644B2 (en) | 2016-06-23 | 2019-01-29 | Collegium Pharmaceutical, Inc | Process of making stable abuse-deterrent oral formulations |
US10646485B2 (en) | 2016-06-23 | 2020-05-12 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
CN110507658A (zh) * | 2019-09-18 | 2019-11-29 | 国药集团致君(深圳)制药有限公司 | 头孢呋辛酯药物组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
ATA415075A (de) | 1977-09-15 |
JPS516869A (ja) | 1976-01-20 |
DE2426812A1 (de) | 1976-01-02 |
AT343083B (de) | 1978-05-10 |
NL7506615A (nl) | 1975-12-08 |
FR2273584A1 (fr) | 1976-01-02 |
BE829449A (fr) | 1975-09-15 |
LU72652A1 (de) | 1975-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1513166A (en) | Method of making granules | |
IL59914A (en) | Esters of acyl-carnitines,process for their preparation and pharmaceutical compositions containing them | |
DE3064173D1 (en) | Novel 20-0-acylmaytansinoids, process for their preparation and pharmaceutical compositions containing them | |
IL59893A0 (en) | Pancreatin pellets,their preparation and pharmaceutical compositions containing them | |
AU7206981A (en) | Retarded release pharmaceutical compositions | |
DE2961289D1 (en) | Pyrimidones, processes for their preparation and pharmaceutical compositions containing them | |
IL56991A (en) | 4-halo-3-oxoandrost-4-ene-17 beta-thiocarboxylic acid esters,their preparation and pharmaceutical compositions containing them | |
IL57662A (en) | Acyl-esters of carnitine,process for their preparation and pharmaceutical compositions comprising them | |
DE2960954D1 (en) | 1-aryloxy-3-nitratoalkylamino-2-propanols, process for their preparation and pharmaceutical compositions | |
GB2057244B (en) | Process for the preparation of new lysinecontaining solid compositions for addition to animal feed | |
EP0006614A3 (en) | Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same | |
GB2019837B (en) | N - oxacyclic - alkylpiperidyl - diaza compounds process for their manufacture and pharmaceutical compositions contaaining them | |
ZA786054B (en) | Novel 6-oxy-genated-3,20-dioxo-pregnane-derivatives,process for the preparation thereof,and pharmaceutical compositions containing them | |
DE3065460D1 (en) | Benzocycloheptapyrrolealkanoic acids and their derivatives, processes for their preparation and pharmaceutical compositions containing them | |
GB2044756B (en) | Fluoro-amines processes for their preparation and pharmaceutical compositions containing them | |
GB2050833B (en) | Pharmaceutical compositions and process for the preparation thereof | |
IL60468A (en) | 4-sulfamoylphenyl-2-phenyl-imino-1,3-thiazole derivatives,process for their preparation and pharmaceutical compositions containing them | |
GB2038802B (en) | Aryltrifluoroethanols process for their preparation and pharmaceutical compositions containing them | |
DE3060079D1 (en) | Spiro-quinolylhydantoins, process for their preparation and pharmaceutical compositions thereof | |
IL60907A0 (en) | Substituted quinoline-alkanecarboxylic acids,process for their preparation and pharmaceutical compositions containing them | |
DE2960503D1 (en) | Novel androstadienes, processes for their preparation and pharmaceutical compositions containing them | |
JPS5238984A (en) | Clay composition for handicrafts | |
DE2960090D1 (en) | Testosterone esters, process for their preparation and pharmaceutical compositions containing them | |
GB2037773B (en) | Process for preparing stabilised vitamin d and compositions thereof | |
DE3067174D1 (en) | Tetrahydro-fluorene compounds, processes for their preparation and pharmaceutical compositions thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |